Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The Lancet. Infectious Diseases
|
May 14, 2019
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial
Robert W Frenck, John Ervin, Laurence Chu, et al.
Clinical Pharmacokinetics
|
June 19, 2016
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study
Stephan Glund, Joachim Stangier, Joanne van Ryn, et al.
The Journal of Urology
|
October 20, 2020
Epidemiology and O-Serotypes of Extraintestinal Pathogenic <i>Escherichia coli</i> Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
The Journal of Urology
|
January 6, 2021
Reply by Authors
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
The Journal of Infectious Diseases
|
October 19, 2022
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months
Arabella S V Stuart, Miia Virta, Kristi Williams, et al.
The Journal of Infectious Diseases
|
January 5, 2021
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
Jerald Sadoff, Els De Paepe, John DeVincenzo, et al.
Antimicrobial Agents and Chemotherapy
|
October 8, 2008
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir
Marian Iwamoto, Larissa A Wenning, Amelia S Petry, et al.
Journal of Clinical Pharmacology
|
May 27, 2016
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects
Rajesh Krishna, Carol Addy, Daniel Tatosian, et al.
Open Forum Infectious Diseases
|
September 2, 2024
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
Joanne M Langley, Terry M Nolan, Mika Rämet, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The Lancet. Infectious Diseases
|
May 14, 2019
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial
Robert W Frenck, John Ervin, Laurence Chu, et al.
Clinical Pharmacokinetics
|
June 19, 2016
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study
Stephan Glund, Joachim Stangier, Joanne van Ryn, et al.
The Journal of Urology
|
October 20, 2020
Epidemiology and O-Serotypes of Extraintestinal Pathogenic <i>Escherichia coli</i> Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
The Journal of Urology
|
January 6, 2021
Reply by Authors
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
The Journal of Infectious Diseases
|
October 19, 2022
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months
Arabella S V Stuart, Miia Virta, Kristi Williams, et al.
The Journal of Infectious Diseases
|
January 5, 2021
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
Jerald Sadoff, Els De Paepe, John DeVincenzo, et al.
Antimicrobial Agents and Chemotherapy
|
October 8, 2008
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir
Marian Iwamoto, Larissa A Wenning, Amelia S Petry, et al.
Journal of Clinical Pharmacology
|
May 27, 2016
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects
Rajesh Krishna, Carol Addy, Daniel Tatosian, et al.
Open Forum Infectious Diseases
|
September 2, 2024
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
Joanne M Langley, Terry M Nolan, Mika Rämet, et al.
Page
of 2